Physician profile
David Binder
NPI 1629463153
$818.00
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2021: $358 · 2022: $160 · 2023: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $228.04 | 2020-2022 | |
| Foundation Medicine, INC. | $202.16 | 2021 | |
| Merit Medical Systems INC | $175.00 | 2023 | |
| Glaxosmithkline, LLC. | $120.23 | 2021 | |
| Janssen Biotech, INC. | $56.89 | 2022 | |
| Myriad Genetic Laboratories, INC. | $35.68 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Binder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.